Prana Biotechnology Ltd (PRAN) 2.16 $PRAN
3 Biotech Stocks Under $10 in Breakout Territory
at The Street - Fri Aug 29, 6:00AM CDT
These under-$10 biotech stocks are within range of triggering breakout trades.
Prana Alzheimer's disease Development Program update
PR Newswire - Thu Jul 17, 3:10PM CDT
Prana Biotechnology (NASDAQ: PRAN; ASX: PBT) has today provided an update on its clinical development program for Alzheimer's disease.
Why Prana Biotechnology (PRAN) Stock Is Surging Today
at The Street - Thu Jul 17, 1:05PM CDT
Prana Biotechnology (PRAN) surged Thursday after the company announced a new sub-analysis of its failed study Phase II of PBT2 in Alzheimer's disease.
Investors look to Lighten Up on Shares of Prana Biotechnology, Shares Down 8.5% (PRAN)
Comtex SmarTrend(R) - Tue Jul 15, 11:40AM CDT
Prana Biotechnology (NASDAQ
RAN) is one of today's worst performing low-priced stocks, down 8.5% to $2.26 on 1.0x average daily volume. Prana Biotechnology has traded 1.3 million shares thus far today, vs. average volume of 1.3 million shares per day. The stock has underperformed the Dow (-8.5% to the Dow's -0.1%) and underperformed the S&P 500 (-8.5% to the S&P's -0.4%) during today's trading.
Biotech Equities Technical Momentum -- Research on Organovo, Prana Biotechnology, Isis Pharma, and Pharmacyclics
PR Newswire - Mon Jul 14, 6:04AM CDT
On Friday, July 11, 2014, the NASDAQ Composite ended at 4,415.49, up 0.44%, the Dow Jones Industrial Average advanced 0.17%, to finish the day at 16,943.81, and the S&P 500 closed at 1,967.57, up 0.15%. The gains were broad based as eight out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 712.90, up 0.14%, with the index also advancing 10.01% in the previous three months. Investor-Edge has initiated coverage on the following equities: Organovo Holdings Inc. (NYSE MKT: ONVO), Prana Biotechnology Ltd (NASDAQ: PRAN), Isis Pharmaceuticals Inc. (NASDAQ: ISIS) and Pharmacyclics Inc. (NASDAQ: PCYC). Free technical research on ONVO, PRAN, ISIS and PCYC can be downloaded upon signing up at:
Executive Appointments and Technical Updates - Analyst Notes on Aeri Pharmaceuticals, DaVita, Prana Biotechnology, Raptor and Avanir Pharmaceuticals
PR Newswire - Mon Jul 14, 4:10AM CDT
Today, Analysts Review released its analysts' notes regarding Aeri Pharmaceuticals, Inc. (NASDAQ: AERI), DaVita HealthCare Partners Inc. (NYSE: DVA), Prana Biotechnology Ltd. (NASDAQ: PRAN), Raptor Pharmaceuticals Corp. (NASDAQ: RPTP) and Avanir Pharmaceuticals (NASDAQ: AVNR). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4726-100free.
5 Stocks Under $10 Set to Soar
at The Street - Fri Jul 11, 5:46AM CDT
These under-$10 stocks look ready to break out and trade higher from current levels.
Hot Stock: Prana Biotechnology, Shares Gain 6.7% (PRAN)
Comtex SmarTrend(R) - Wed Jul 09, 10:08AM CDT
Prana Biotechnology (NASDAQ RAN) is one of today's best performing low-priced stocks, up 6.7% to $2.55 on 2.3x average daily volume. Prana Biotechnology has traded 3.3 million shares thus far today, vs. average volume of 1.4 million shares per day. The stock has outperformed the Dow (6.7% to the Dow's 0.2%) and outperformed the S&P 500 (6.7% to the S&P's 0.3%) during today's trading.
5 Stocks Under $10 Setting Up to Soar
at The Street - Thu Jun 26, 12:56PM CDT
These under-$10 stocks look poised to break out and trade higher from current levels.
4 Stocks Under $10 to Trade for Breakouts
at The Street - Thu Jun 19, 5:00AM CDT
These under-$10 stocks are within range of triggering breakout trades.
FDA Panel Grants Market Approval of MannKind Corp.'s Inhalable Insulin
ACCESSWIRE - Wed Apr 02, 8:49AM CDT
On Apr. 1, MannKind Corp. (NASDAQ:MNKD) announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the FDA voted 13 to 1 to recommend that Afrezza, its inhalable insulin, be granted marketing approval by the FDA to improve glycemic control in adults with type 1 diabetes.
Why Prana Biotechnology (PRAN) Stock Is Down Today
at The Street - Tue Apr 01, 9:13AM CDT
Prana Biotechnology (PRAN) continued to decline on Tuesday after the company announced on Monday its phase II study of PBT2 in Alzheimer's disease failed. The experimental drug did not reach the study's main endpoint of a statistically significant...
Downgrade Alert for Prana Biotechnology (PRAN)
Comtex SmarTrend(R) - Tue Apr 01, 7:03AM CDT
Prana Biotechnology (NASDAQ RAN) was downgraded from Buy to Neutral at H.C. Wainwright today. The stock closed yesterday at $2.80 on volume of 23.6 million shares, above average daily volume of 2.9 million. In the past 52 weeks, shares of Prana Biotechnology have traded between a low of $2.12 and a high of $13.29 and closed yesterday at $2.80, which is 32% above that low price. Over the past week, the 200-day moving average (MA) has gone up 1.3% while the 50-day MA has advanced 0.6%.
Coca-Cola Falls as Soda Sales Drop for 9th Straight Year
ACCESSWIRE - Tue Apr 01, 12:59AM CDT
Bank of America Corporation (NYSE: BAC) - For an in-depth report on Bank of America Corporation follow: www.BullTrends.com/stockquote/BAC
Investor Beat: The End of the First Quarter -- How Did We Do?
Chris Hill, The Motley Fool - Motley Fool - Mon Mar 31, 6:50PM CDT
The first quarter of 2014 officially wrapped up today, and though the Dow, Nasdaq and S&P were all up today, the quarter itself was the worst since the end of 2012. Are stocks finally pulling back enough for investors to find value on the market...
Big Movers Today: Panera, Delta, GM, and Prana Biotechnology
Chris Hill, The Motley Fool - Motley Fool - Mon Mar 31, 6:34PM CDT
Shares of Panera Bread moved upward today, after the stock got an analyst upgrade from Wedbush. Delta Airlines stock is also on the rise, after announcing a partnership with Virgin Atlantic. Shares of General Motors fell today in advance of...
Down 70%: Is Prana Biotechnology Ltd. a Buy?
David Williamson, The Motley Fool - Motley Fool - Mon Mar 31, 6:03PM CDT
The biggest loser today in the biotech space was Prana Biotechnology , down a massive 70% because its candidate Alzheimer's drug PBT2 failed its phase 2 trial. The drug failed not only to improve cognitive function, but it also failed to affect...
Lions Gate and Prana are big market movers
By The Associated Press - AP - Mon Mar 31, 3:57PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:
Why Prana Biotechnology Limited Got Pummeled
Brian Pacampara, The Motley Fool - Motley Fool - Mon Mar 31, 1:22PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Prana Biotechnology Limited plummeted 70%...
3 Biotech Stocks Under $10 in Breakout Territory
at The Street - Fri Aug 29, 6:00AM CDT
These under-$10 biotech stocks are within range of triggering breakout trades.
Prana Alzheimer's disease Development Program update
PR Newswire - Thu Jul 17, 3:10PM CDT
Prana Biotechnology (NASDAQ: PRAN; ASX: PBT) has today provided an update on its clinical development program for Alzheimer's disease.
Why Prana Biotechnology (PRAN) Stock Is Surging Today
at The Street - Thu Jul 17, 1:05PM CDT
Prana Biotechnology (PRAN) surged Thursday after the company announced a new sub-analysis of its failed study Phase II of PBT2 in Alzheimer's disease.
Investors look to Lighten Up on Shares of Prana Biotechnology, Shares Down 8.5% (PRAN)
Comtex SmarTrend(R) - Tue Jul 15, 11:40AM CDT
Prana Biotechnology (NASDAQ
RAN) is one of today's worst performing low-priced stocks, down 8.5% to $2.26 on 1.0x average daily volume. Prana Biotechnology has traded 1.3 million shares thus far today, vs. average volume of 1.3 million shares per day. The stock has underperformed the Dow (-8.5% to the Dow's -0.1%) and underperformed the S&P 500 (-8.5% to the S&P's -0.4%) during today's trading. Biotech Equities Technical Momentum -- Research on Organovo, Prana Biotechnology, Isis Pharma, and Pharmacyclics
PR Newswire - Mon Jul 14, 6:04AM CDT
On Friday, July 11, 2014, the NASDAQ Composite ended at 4,415.49, up 0.44%, the Dow Jones Industrial Average advanced 0.17%, to finish the day at 16,943.81, and the S&P 500 closed at 1,967.57, up 0.15%. The gains were broad based as eight out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 712.90, up 0.14%, with the index also advancing 10.01% in the previous three months. Investor-Edge has initiated coverage on the following equities: Organovo Holdings Inc. (NYSE MKT: ONVO), Prana Biotechnology Ltd (NASDAQ: PRAN), Isis Pharmaceuticals Inc. (NASDAQ: ISIS) and Pharmacyclics Inc. (NASDAQ: PCYC). Free technical research on ONVO, PRAN, ISIS and PCYC can be downloaded upon signing up at:
Executive Appointments and Technical Updates - Analyst Notes on Aeri Pharmaceuticals, DaVita, Prana Biotechnology, Raptor and Avanir Pharmaceuticals
PR Newswire - Mon Jul 14, 4:10AM CDT
Today, Analysts Review released its analysts' notes regarding Aeri Pharmaceuticals, Inc. (NASDAQ: AERI), DaVita HealthCare Partners Inc. (NYSE: DVA), Prana Biotechnology Ltd. (NASDAQ: PRAN), Raptor Pharmaceuticals Corp. (NASDAQ: RPTP) and Avanir Pharmaceuticals (NASDAQ: AVNR). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4726-100free.
5 Stocks Under $10 Set to Soar
at The Street - Fri Jul 11, 5:46AM CDT
These under-$10 stocks look ready to break out and trade higher from current levels.
Hot Stock: Prana Biotechnology, Shares Gain 6.7% (PRAN)
Comtex SmarTrend(R) - Wed Jul 09, 10:08AM CDT
Prana Biotechnology (NASDAQ
RAN) is one of today's best performing low-priced stocks, up 6.7% to $2.55 on 2.3x average daily volume. Prana Biotechnology has traded 3.3 million shares thus far today, vs. average volume of 1.4 million shares per day. The stock has outperformed the Dow (6.7% to the Dow's 0.2%) and outperformed the S&P 500 (6.7% to the S&P's 0.3%) during today's trading. 5 Stocks Under $10 Setting Up to Soar
at The Street - Thu Jun 26, 12:56PM CDT
These under-$10 stocks look poised to break out and trade higher from current levels.
4 Stocks Under $10 to Trade for Breakouts
at The Street - Thu Jun 19, 5:00AM CDT
These under-$10 stocks are within range of triggering breakout trades.
FDA Panel Grants Market Approval of MannKind Corp.'s Inhalable Insulin
ACCESSWIRE - Wed Apr 02, 8:49AM CDT
On Apr. 1, MannKind Corp. (NASDAQ:MNKD) announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the FDA voted 13 to 1 to recommend that Afrezza, its inhalable insulin, be granted marketing approval by the FDA to improve glycemic control in adults with type 1 diabetes.
Why Prana Biotechnology (PRAN) Stock Is Down Today
at The Street - Tue Apr 01, 9:13AM CDT
Prana Biotechnology (PRAN) continued to decline on Tuesday after the company announced on Monday its phase II study of PBT2 in Alzheimer's disease failed. The experimental drug did not reach the study's main endpoint of a statistically significant...
Downgrade Alert for Prana Biotechnology (PRAN)
Comtex SmarTrend(R) - Tue Apr 01, 7:03AM CDT
Prana Biotechnology (NASDAQ
RAN) was downgraded from Buy to Neutral at H.C. Wainwright today. The stock closed yesterday at $2.80 on volume of 23.6 million shares, above average daily volume of 2.9 million. In the past 52 weeks, shares of Prana Biotechnology have traded between a low of $2.12 and a high of $13.29 and closed yesterday at $2.80, which is 32% above that low price. Over the past week, the 200-day moving average (MA) has gone up 1.3% while the 50-day MA has advanced 0.6%. Coca-Cola Falls as Soda Sales Drop for 9th Straight Year
ACCESSWIRE - Tue Apr 01, 12:59AM CDT
Bank of America Corporation (NYSE: BAC) - For an in-depth report on Bank of America Corporation follow: www.BullTrends.com/stockquote/BAC
Investor Beat: The End of the First Quarter -- How Did We Do?
Chris Hill, The Motley Fool - Motley Fool - Mon Mar 31, 6:50PM CDT
The first quarter of 2014 officially wrapped up today, and though the Dow, Nasdaq and S&P were all up today, the quarter itself was the worst since the end of 2012. Are stocks finally pulling back enough for investors to find value on the market...
Big Movers Today: Panera, Delta, GM, and Prana Biotechnology
Chris Hill, The Motley Fool - Motley Fool - Mon Mar 31, 6:34PM CDT
Shares of Panera Bread moved upward today, after the stock got an analyst upgrade from Wedbush. Delta Airlines stock is also on the rise, after announcing a partnership with Virgin Atlantic. Shares of General Motors fell today in advance of...
Down 70%: Is Prana Biotechnology Ltd. a Buy?
David Williamson, The Motley Fool - Motley Fool - Mon Mar 31, 6:03PM CDT
The biggest loser today in the biotech space was Prana Biotechnology , down a massive 70% because its candidate Alzheimer's drug PBT2 failed its phase 2 trial. The drug failed not only to improve cognitive function, but it also failed to affect...
Lions Gate and Prana are big market movers
By The Associated Press - AP - Mon Mar 31, 3:57PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:
Why Prana Biotechnology Limited Got Pummeled
Brian Pacampara, The Motley Fool - Motley Fool - Mon Mar 31, 1:22PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Prana Biotechnology Limited plummeted 70%...
